Early research (Phase 1)Ended earlyNCT01611675What this trial is testingLeflunomide+Vemurafenib in V600 Mutant Met. MelanomaWho this might be right forMelanoma Massachusetts General Hospital 3
Not applicableStudy completedNCT03325257What this trial is testingPost-ATU Study of NivolumabWho this might be right forMelanoma Nantes University Hospital 350
Early research (Phase 1)Study completedNCT00161187What this trial is testingIrradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid TumorWho this might be right forCancer University of Medicine and Dentistry of New Jersey 37
Early research (Phase 1)Ended earlyNCT01810016What this trial is testingNY-ESO-1 Vaccine in Combination With Ipilimumab in Patients With Unresectable or Metastatic MelanomaWho this might be right forUnresectable or Metastatic Melanoma Ludwig Institute for Cancer Research 8
Large-scale testing (Phase 3)Active Not RecruitingNCT02224781What this trial is testingDabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and Nivolumab Followed by Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAFV600 MelanomaWho this might be right forClinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8Metastatic Melanoma+2 more National Cancer Institute (NCI) 267
Testing effectiveness (Phase 2)WithdrawnNCT01531244What this trial is testingIsolated Limb Infusion Chemotherapy With Targeted Gene Therapy for Advanced, Unresectable Extremity MelanomaWho this might be right forMelanoma Washington University School of Medicine
Early research (Phase 1)Study completedNCT01005472What this trial is testingTemozolomide and Sunitinib Malate in Treating Patients With Stage III or Stage IV Malignant MelanomaWho this might be right forMetastatic Melanoma Jonsson Comprehensive Cancer Center 16
Testing effectiveness (Phase 2)Active Not RecruitingNCT03767348What this trial is testingStudy of RP1 Monotherapy and RP1 in Combination With Nivolumab (IGNYTE)Who this might be right forNon-Small Cell Lung Cancer (NSCLC)Microsatellite Instability-High (MSI-H)Non-melanoma Skin Cancer (NMSC)+1 more Replimune, Inc. 340
Testing effectiveness (Phase 2)Active Not RecruitingNCT05912244What this trial is testingIO102/IO103, Nivolumab, and Relatlimab in People With MelanomaWho this might be right forMelanoma Memorial Sloan Kettering Cancer Center 43
Testing effectiveness (Phase 2)Active Not RecruitingNCT04417621What this trial is testingStudy of Efficacy and Safety of LXH254 Combinations in Patients With Previously Treated Unresectable or Metastatic MelanomaWho this might be right forMelanoma Novartis Pharmaceuticals 134
Early research (Phase 1)WithdrawnNCT06626256What this trial is testingSTIL101 for Injection for the Treatment of Locally Advanced, Metastatic or Unresectable Pancreatic Cancer, Colorectal Cancer, Renal Cell Cancer, Cervical Cancer and MelanomaWho this might be right forLocally Advanced Cervical CarcinomaLocally Advanced Colorectal CarcinomaLocally Advanced Malignant Solid Neoplasm+24 more City of Hope Medical Center
Testing effectiveness (Phase 2)Looking for participantsNCT05086692What this trial is testingA Beta-only IL-2 ImmunoTherapY StudyWho this might be right forAdvanced Solid TumorUnresectable Solid TumorClear Cell Renal Cell Carcinoma+34 more Medicenna Therapeutics, Inc. 115
Testing effectiveness (Phase 2)Study completedNCT01654692What this trial is testingA Combination of Ipilimumab and Fotemustine for Treat Unresectable Locally Advanced or Metastatic MelanomaWho this might be right forMetastatic Malignant Melanoma Italian Network for Tumor Biotherapy 86
Early research (Phase 1)Study completedNCT03864042What this trial is testingPharmacokinetic Drug-drug Interaction Study of Encorafenib and Binimetinib on Probe Drugs in Patients With BRAF V600-mutant Melanoma or Other Advanced Solid TumorsWho this might be right forAdvanced Solid TumorsMetastatic Melanoma Pfizer 56
Early research (Phase 1)Study completedNCT01673737What this trial is testingA Phase I/Ib Trial for the Evaluation of SAR260301 in Monotherapy or in Combination With Vemurafenib in Patients With Various Advanced CancerWho this might be right forNeoplasm Malignant Sanofi 75
Testing effectiveness (Phase 2)Study completedNCT03153085What this trial is testingCombination with TBI-1401(HF10) and Ipilimumab in Japanese Patients with Unresectable or Metastatic MelanomaWho this might be right forMelanoma Stage IIIMelanoma Stage IV Takara Bio Inc. 28
Large-scale testing (Phase 3)Ended earlyNCT02263508What this trial is testingPembrolizumab With Talimogene Laherparepvec or Placebo in Unresected MelanomaWho this might be right forMelanoma Amgen 713
Early research (Phase 1)Study completedNCT01496807What this trial is testingYervoy With Sylatron Unresectable Stage 3 or 4 MelanomaWho this might be right forMelanoma H. Lee Moffitt Cancer Center and Research Institute 31
Not applicableStudy completedNCT00477919What this trial is testingE-MOSAIC Electronic Tool to Monitor SymptomsWho this might be right forCancer Swiss Cancer Institute 264
Testing effectiveness (Phase 2)Study completedNCT01927419What this trial is testingStudy of Nivolumab (BMS-936558) Plus Ipilimumab Compared With Ipilimumab Alone in the Treatment of Previously Untreated, Unresectable, or Metastatic MelanomaWho this might be right forUnresectable MelanomaMetastatic Melanoma Bristol-Myers Squibb 142